Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) announced a non-brokered private placement of 6,764,069 units at C$0.7392 per unit, raising approximately C$5 million. The financing, expected to close on or about July 10, 2026, is subject to regulatory approvals including from Cboe Canada. Each unit consists of one common share and one warrant exercisable at C$0.90 per share for three years.
The proceeds will be allocated to advance the company's ONC010 program through manufacturing and preclinical testing, support development of its SynoGraph platform, and provide working capital for general corporate purposes. The offering is being conducted under Canada's Listed Issuer Financing Exemption, meaning securities issued will not be subject to a hold period under applicable Canadian securities laws.
Onco-Innovations is a Canadian-based company focused on cancer research and treatment, specializing in oncology. The company's mission is to pursue the prevention and treatment of cancer through pioneering research and innovative solutions. It has secured an exclusive worldwide license to patented technology that targets solid tumors.
This capital raise is significant for Onco-Innovations as it seeks to advance its pipeline toward clinical development. The ONC010 program, which targets solid tumors, could address a large unmet medical need if successful. Solid tumors represent the majority of cancer cases, and effective treatments are a high priority in oncology. The SynoGraph platform may also have broader applications in drug development and diagnostics.
For the industry, Onco-Innovations' progress could contribute to the growing field of targeted cancer therapies. The company's exclusive license to patented technology provides a competitive edge, and successful development could lead to partnerships or licensing opportunities with larger pharmaceutical companies. Investors should monitor the company's preclinical results and regulatory milestones as indicators of future value.
For more information, view the full press release at https://www.nnw.fm/QatCe and the company's newsroom at https://nnw.fm/ONNVF.
